Making method of aggrecanases inhibitor combined with in-vitro cross-linked hyaluronic acid hydrogel and application thereof in drugs for treating osteoarthritis
Patent Information
- Authority / Receiving Office
- CN · China
- Current Assignee / Owner
- ZHEJIANG UNIV
- Publication Date
- 2015-09-30
- Estimated Expiration
- Not applicable · inactive patent
Smart Images
Figure 1 Figure 2 Figure 3
Abstract
Description
technical field
[0001] The invention relates to the application of a proteoglycanase inhibitor combined with externally linked hyaluronic acid hydrogel, in particular to its application in the preparation of medicines for treating osteoarthritis. Background technique
[0002] Osteoarthritis is one of the most common orthopedic diseases. According to statistics, in the West alone, about 12% of the middle-aged and elderly people suffer from different degrees of osteoarthritis. In the United States, there are more than 27 million people suffering from osteoarthritis, and the prevalence rate of people over 60 years old can reach more than 50%. A study by the Center for Disease Control and Prevention of the United States and the Department of Public Health of Harvard University shows that osteoarthritis is One of the five major diseases that cause disability in older adults. Osteoarthritis is characterized by the collapse and necrosis of articular surface cartilage, accompanied ...